Can Micro Needling be harmful in long term?
    Microneedling 7/7/2025

    From the encyclopedia
    Dutasteride →

    Heavy duty finasteride that comes with higher risks

    Microneedling →

    technique to create small wounds in skin to activate collagen production and hair growth

    At a glance
    In this question or advice post, the primary subjects mentioned are
    💊 Oral Minoxidil (oral) 2.5mg once a day 3 years
    💧 Minoxidil Foam (topical) 5% once at night 3 years
    💊 Dutasteride (oral) 0.5mg 3 years
    💧 Microneedling (topical) 0.5mm every 15 days
    the tone is 😐 neutral.

    Other terms

    The conversation discusses the use of microneedling for hair loss, with concerns about potential long-term effects like fibrosis and scarring. Users share experiences and opinions on combining microneedling with treatments like minoxidil and finasteride, but there is uncertainty about the long-term safety and efficacy.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results
      Androgenetic Alopecia: An Update

      research Androgenetic alopecia: An update

      July 2023 in “JAAD International”
      This study describes androgenetic alopecia as a common non-scarring hair loss condition primarily influenced by genetic factors and androgen sensitivity, notably impacting psychosocial well-being, especially in females and younger males seeking treatment.
      Applications and Efficacy of Minoxidil in Dermatology

      research Applications and efficacy of minoxidil in dermatology

      November 2024 in “Skin Health and Disease”
      This review suggests that while minoxidil is effective in promoting hair growth, its precise mechanism remains unclear, and it may have emerging applications in treating various dermatological conditions.
      Androgenetic Alopecia: Therapy Update

      research Androgenetic Alopecia: Therapy Update

      May 2023 in “Drugs”
      This comprehensive review analyzes androgenetic alopecia treatments, discussing the mechanisms, costs, efficacy, and safety of FDA-approved drugs like minoxidil and finasteride, as well as newer non-FDA-approved options that have shown effectiveness across various studies.

      research Male androgenetic alopecia

      January 2025 in “Anais Brasileiros de Dermatologia”
      This review examines male androgenetic alopecia and reports no new clinical results, offering insights to aid dermatologists in making informed therapeutic decisions.